Bioventus (BVS) Enterprise Value (QoQ) (2020 - 2026)
Bioventus (BVS) Enterprise Value (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Bioventus | 826.57 Mn | 790.72 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 238.02% |
| Dec 31, 2025 | -586.17% |
| Sep 27, 2025 | -114.06% |
| Jun 28, 2025 | -50.82% |
| Mar 29, 2025 | 470.93% |
| Dec 31, 2024 | 21.31% |
| Sep 28, 2024 | -181.18% |
| Jun 29, 2024 | -70.77% |
| Mar 30, 2024 | 98.65% |
| Dec 31, 2023 | -52.20% |
| Sep 30, 2023 | 6.47% |
| Jul 1, 2023 | 337.08% |
| Apr 1, 2023 | -91.64% |
| Dec 31, 2022 | 4,053.26% |
| Oct 1, 2022 | -95.62% |
| Jul 2, 2022 | -20.97% |
| Apr 2, 2022 | -56.83% |
| Dec 31, 2021 | 272.84% |
| Oct 2, 2021 | 15.00% |
| Jul 3, 2021 | -9.68% |